Induction of β-cell proliferation and retinoblastoma protein phosphorylation in rat and human islets using adenovirus-mediated transfer of cyclin-dependent kinase-4 …

I Cozar-Castellano, KK Takane, R Bottino… - Diabetes, 2004 - Am Diabetes Assoc
I Cozar-Castellano, KK Takane, R Bottino, AN Balamurugan, AF Stewart
Diabetes, 2004Am Diabetes Assoc
The major regulator of the gap-1/synthesis phase (G1/S) cell cycle checkpoint is the
retinoblastoma protein (pRb), and this is regulated in part by the activities of cyclin-
dependent kinase (cdk)-4 and the D cyclins. Surprisingly, given the potential importance of β-
cell replication for islet replacement therapy, pRb presence, phosphorylation status, and
function have not been explored in β-cells. Here, adenoviruses expressing cdk-4 and cyclin
D1 were used to explore rat and human pRb phosphorylation and β-cell cycle control. pRb …
The major regulator of the gap-1/synthesis phase (G1/S) cell cycle checkpoint is the retinoblastoma protein (pRb), and this is regulated in part by the activities of cyclin-dependent kinase (cdk)-4 and the D cyclins. Surprisingly, given the potential importance of β-cell replication for islet replacement therapy, pRb presence, phosphorylation status, and function have not been explored in β-cells. Here, adenoviruses expressing cdk-4 and cyclin D1 were used to explore rat and human pRb phosphorylation and β-cell cycle control. pRb is present in rat and human islets, and overexpression of cyclin D1/cdk-4 led to strikingly enhanced pRb phosphorylation in both species. Combined overexpression of both cdk-4 and cyclin D1 caused a threefold increase in [3H]thymidine incorporation. This increase in proliferation was confirmed independently using insulin and bromodeoxyuridine immunohistochemistry, where human β-cell replication rates were increased 10-fold. Cdk-4 or cyclin D1 overexpression did not adversely effect β-cell differentiation or function. The key cell cycle regulatory protein, pRb, can be harnessed to advantage using cyclin D1/cdk-4 for the induction of human and rodent β-cell replication, enhancing replication without adversely affecting function or differentiation. This approach will allow detailed molecular study of the cellular mechanisms regulating the cell cycle in β-cells, β-cell lines, and stem cell-derived β-cells.
Am Diabetes Assoc